研究者
J-GLOBAL ID:202001001848445412
更新日: 2024年11月05日
今井 久雄
イマイ ヒサオ | IMAI Hisao
所属機関・部署:
職名:
准教授
論文 (37件):
-
Koki Ito, Kyoichi Kaira, Hisao Imai, Ayako Shiono, Kosuke Hashimoto, OU Yamaguchi, Hiroshi Kagamu. Therapeutic Resistance in G-CSF Producing Lung Cancer With <I>EGFR</I> Mutation. CANCER DIAGNOSIS & PROGNOSIS. 2024. 4. 4. 529-533
-
Kyoichi Kaira, Atsuto Mouri, Hisao Imai, Ou Yamaguchi, Hiroshi Kagamu. Clinical Issue of Myasthenia Gravis Related to Immune Checkpoint Inhibitors. Current Oncology Reports. 2024
-
Kaira K, Ikezawa T, Inoue T, Imai H, Okada H, Kagamu H. MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer. Journal of Chemother. 2024. 36. 1. 82-83
-
Yamaguchi O, Kaira K, Imai H, Mouri A, Shiono A, Miura Y, Hashimoto K, Kobayashi K, Kagamu H. Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer. Oncology. 2024. 102. 3. 271-282
-
Kasai T, Mori K, Nakamura Y, Seki N, Ichikawa Y, Saito H, Kondo T, Nishikawa K, Otsu S, Bessho A, et al. Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321. Cancer Medicine. 2023. 12. 14. 14988-4999
もっと見る
前のページに戻る